Key result
Bendopnea in HF is linked to ~121% higher mortality.
Why the study?
The clinical significance of bendopnea in heart failure patients was not well defined and required synthesis of available evidence.
Does the presence of bendopnea predict increased mortality and symptom burden in patients with heart failure?
Meta-Analysis (n=891)
Does the presence of bendopnea predict increased mortality and symptom burden in patients with heart failure?
Bendopnea is a valuable clinical sign in heart failure that is strongly associated with advanced symptom burden and increased mortality.
Answers are grounded in this paper and cite their sources.
Bendopnea may flag higher mortality risk in heart failure; leaves open its incremental value for risk stratification beyond standard markers.
BACKGROUND: Bendopnea is a symptom mediated by increased ventricular filling pressure during bending forward. Presence of bendopnea in patients can be easily evaluated without additional maneuver in several countries whose norms, habits, culture, and occupation relates to a higher frequency of bending forward. This information may prove valuable in routine clinical practice. We aimed to analyze the latest evidence on bendopnea in order to further define the clinical significance of this symptom. METHODS: We performed a comprehensive search on bendopnea in heart failure from inception up until January 2019 through PubMed, EuropePMC, EBSCOhost, Cochrane Central Database, and ClinicalTrials.gov. RESULTS: There were 283 patients (31.76%) who have bendopnea, and a total of 891 patients from six studies were included. Bendopnea was associated with the presence of dyspnea [odds ratio (OR) 69.70 (17.35-280.07); <0.001], orthopnea [OR 3.02 (2.02-4.52); <0.001], paroxysmal nocturnal dyspnea [OR 2.76 (1.76-4.32); <0.001], and abdominal fullness [OR 7.50 (4.15-13.58); <0.001]. Association with elevated jugular venous pressure was shown in two studies. New York Heart Association (NYHA) functional class IV was more prevalent in patients with bendopnea [OR 7.58 (4.35-13.22); <0.001]. Bendopnea was also associated with increased mortality [OR 2.21 (1.34-3.66); 0.002]. CONCLUSION: Bendopnea is associated with the presence of several signs and symptoms. This study also showed that bendopnea is one of the signs and symptoms of advanced heart failure associated with increased mortality. However, owing to the limited number of studies, further investigation is needed before drawing a definite conclusion.
No takes yet. Share an insight, caveat, or question.
Pranata et al. (2019) conducted a meta-analysis in heart failure (n=891). Bendopnea vs. Absence of bendopnea was evaluated on mortality (OR 2.21, 95% CI 1.34-3.66, p=0.002). In patients with heart failure, bendopnea was significantly associated with increased mortality (OR 2.21; 95% CI 1.34-3.66; P=0.002).
Synapse has enriched 10 related papers. Consider them for comparative context: